Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001601485-21-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-20 | 2021-12-16+ | ELTX | Venkatesan Jay | See Remarks, Dir | P - Purchase | $2.55 | +41.6K | 1.34M | +3% | +$106.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-17 | P | A | 13,742 | $2.54 | 1,358,486 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55 inclusive. |
| 2 | Common | Common Stock | 2021-12-16 | P | A | 27,883 | $2.55 | 1,344,744 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.55 inclusive. |